Chief Financial Officer · TriSalus Life Sciences, Inc. (TLSI)

Sean Murphy

A named executive officer of TriSalus Life Sciences in every fiscal year CompBrief holds from FY2022 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$1,393,246

Salary $471,539Stock awards $171,433

FY2022: $329,597

3rd of 3 named executive officers at TriSalus Life Sciences by FY2023 total.

3 named officers on file for TriSalus Life Sciences, FY2023

Sean Murphy’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how TriSalus Life Sciences’s whole pay program stands against its peers

  • TriSalus Life Sciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TLSI→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed July 19, 2024 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Sean Murphy’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Sean Murphy compensation by year

TriSalus Life Sciences Summary Compensation Table · all 2 fiscal years held
In US dollars, as TriSalus Life Sciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022FY2023
Salary$207,462$471,539
Bonus$0$0
Stock awards$0$171,433
Option awards$122,066$593,066
Non-equity incentive$0$156,158
Pension and deferred compensation$0$0
All other$69$1,050
Total$329,597$1,393,246

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: TriSalus Life Sciences, Inc. DEF 14A filed July 19, 2024, accession 0001826667-24-000034, and prior-year filings.

How this page was built: the TriSalus Life Sciences, Inc. filed document, accession 0001826667-24-000034. Every figure is read from that document and cited to the page and table it appears in. Filed July 19, 2024.

$330K
$1.4M
FY22
FY23
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
RSU12,483$106,605—
Option5,536—$12.00
Option56,964—$12.00
Option2,266—$2.43
Option6,442—$2.43
Option79,815—$2.43
Option17,734—$10.30
Option13,553—$10.30

Per the Outstanding Equity Awards at Fiscal Year-End table in TriSalus Life Sciences, Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

7 Form 4 lines since the FY2023 proxy (filed July 19, 2024)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2025-06-12Grant or award derivative—15,000$0.00554,681
2025-05-19Grant or award—44,884$5.18123,989
2025-02-18Grant or award—15,817$0.0079,105
2025-01-28Purchase—15,000$5.17197,732
2025-01-27Purchase—15,000$5.31182,732
2025-01-27Grant or award derivative—75,000$0.0075,000
2025-01-27Grant or award—12,500$0.0063,288

The 7 most recent of 7 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

TriSalus Life Sciences’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Mary SzelaCEO and President$2,692,830
Steven KatzChief Medical Officer$1,613,005
Sean Murphy · this pageChief Financial Officer$1,393,246

Board service

TriSalus Life Sciences board · FY2023–FY2025
Director compensation in US dollars, as TriSalus Life Sciences reports it. Most recent year first; a dash means the company reported no figure in that column.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$0$74,999$43,749—$118,748
FY2023—————

Each year as the company reported it in TriSalus Life Sciences's director compensation table. Totals are the company's own disclosed totals.

How this board is paid

Company policy: TriSalus Life Sciences pays directors a $50,000 cash retainer. As stated in TriSalus Life Sciences's FY2025 proxy.

The full TriSalus Life Sciences compensation record

free company brief

This page is one person within TriSalus Life Sciences's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are TriSalus Life Sciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Sean Murphy's compensation dossier · One-time report. No refunds.